Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings.

Rodrigues CA, Patah PA, Novis YA, Hosing C, de Lima M.

Curr Hematol Malig Rep. 2011 Mar;6(1):47-57. doi: 10.1007/s11899-010-0075-5. Review.

PMID:
21190142
2.

Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.

Ciurea SO, Saliba RM, Rondon G, Patah PA, Aung F, Cano P, Andersson BS, Kebriaei P, Popat U, Fernandez-Vina M, Champlin RE, de Lima M.

Biol Blood Marrow Transplant. 2011 Jun;17(6):923-9. doi: 10.1016/j.bbmt.2010.10.017. Epub 2010 Oct 20.

3.

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type.

Silva Lde P, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, Han XY, Tarrand J, Ribeiro R, Gulbis A, Shpall EJ, Jones R, Popat U, Walker JA, Petropoulos D, Chiattone A, Stewart J, El-Zimaity M, Anderlini P, Giralt S, Champlin RE, de Lima M.

Haematologica. 2010 Jul;95(7):1183-90. doi: 10.3324/haematol.2009.016758. Epub 2010 Apr 21.

4.

Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation.

Ramos CA, Saliba RM, de Pádua Silva L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Nieto Y, Champlin RE, de Lima M.

Biol Blood Marrow Transplant. 2010 May;16(5):686-94. doi: 10.1016/j.bbmt.2009.12.532. Epub 2010 Jan 6. Erratum in: Biol Blood Marrow Transplant. 2011 May;17(5):770.

5.

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.

Parmar S, Del Lima M, Zou Y, Patah PA, Liu P, Cano P, Rondon G, Pesoa S, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Kebriaei P, Shpall EJ, Giralt S, Champlin RE, Stastny P, Fernandez-Vina M.

Blood. 2009 Oct 1;114(14):2884-7. doi: 10.1182/blood-2009-05-223172. Epub 2009 Aug 4.

6.

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Ramos CA, Saliba RM, de Pádua L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Khouri IF, Nieto YL, Champlin RE, de Lima M.

Haematologica. 2009 Feb;94(2):249-57. doi: 10.3324/haematol.13756. Epub 2009 Jan 14.

7.

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.

de Lima M, Champlin RE, Thall PF, Wang X, Martin TG 3rd, Cook JD, McCormick G, Qazilbash M, Kebriaei P, Couriel D, Shpall EJ, Khouri I, Anderlini P, Hosing C, Chan KW, Andersson BS, Patah PA, Caldera Z, Jabbour E, Giralt S.

Leukemia. 2008 Feb;22(2):258-64. Epub 2007 Nov 8.

PMID:
17989720
8.

Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.

Gurkan E, Patah PA, Saliba RM, Ramos CA, Anderson BS, Champlin R, de Lima M, Lichtiger B.

Bone Marrow Transplant. 2007 Sep;40(5):461-4. Epub 2007 Jun 25.

PMID:
17589530
9.

Microbial contamination of hematopoietic progenitor cell products: clinical outcome.

Patah PA, Parmar S, McMannis J, Sadeghi T, Karandish S, Rondon G, Tarrand J, Champlin R, de Lima M, Shpall EJ.

Bone Marrow Transplant. 2007 Aug;40(4):365-8. Epub 2007 Jun 18.

PMID:
17572714

Supplemental Content

Loading ...
Support Center